Atlas Trials

Amyloidosis Typing Using Mass Spectrometry-based Proteomics: a New Accurate Tool for Difficult Typing

Clinical trial NCT03984721 · COMPLETED

Trial details

NCT number
NCT03984721
Sponsor
University Hospital, Toulouse
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Amyloidosis
Start date
2019-07-25
Primary completion
2021-09-08
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.